Phyto Partners is a venture capital firm that provides debt and equity capital to privately held cannabis companies, focusing on ancillary businesses across the industry's value chain. They also have a dedicated fund for businesses in neurowellness and brain health, including those utilizing psychedelic compounds for mental well-being.
100% of their portfolio is in Fintech. Their most common stage is series-c (50% of deals).
Portfolio
2
Fund Size
$55M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
Top Co-Investors
Last updated: 16 April 2026